Latest Insights VIEW MORE

  • Previous Close 7.20
  • Open 7.19
  • Bid 5.28 x 200
  • Ask 8.85 x 200
  • Day's Range 6.92 - 7.36
  • 52 Week Range 6.61 - 50.40
  • Volume 492,606
  • Avg. Volume 935,995
  • Market Cap (intraday) 219.794M
  • Beta (5Y Monthly) 1.47
  • PE Ratio (TTM) --
  • EPS (TTM) -3.64
  • Earnings Date (est.) Jul 29, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 32.00

Related Tickers

TARS Tarsus Pharmaceuticals, Inc.
59.28 -1.76%
 
JANX Janux Therapeutics, Inc.
13.36 -2.91%
 
RARE Ultragenyx Pharmaceutical Inc.
21.91 -6.01%
 
PCVX Vaxcyte, Inc.
47.36 -2.87%
 
EYPT EyePoint, Inc.
11.78 -3.92%
 
IRD Opus Genetics, Inc.
4.0300 -13.15%
 
OCUL Ocular Therapeutix, Inc.
8.25 -6.25%
 
KOD Kodiak Sciences Inc.
31.05 -9.10%
 
LEGN Legend Biotech Corporation
32.62 -4.62%
 
APGE Apogee Therapeutics, Inc.
86.92 -4.38%
 

Recent Events

May 11, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 28, 2026 at 12:00 AM UTC

DEFA14A: Proxy Statements

March 24, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 7, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 12, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 5, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 8, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 30, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 31, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 30, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Performance

Performance Overview

Trailing total returns as of 6/5/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LENZ
56.19%
S&P 500 (^GSPC)
7.86%

1-Year Return

LENZ
76.86%
S&P 500 (^GSPC)
24.32%

3-Year Return

LENZ
28.68%
S&P 500 (^GSPC)
72.77%

5-Year Return

LENZ
95.47%
S&P 500 (^GSPC)
74.56%

Financials

(Values in U.S. thousands)
Next
  12-2025 12-2024 12-2023 12-2022 12-2021
Sales 19,088 0 0 0 0
Cost of Goods 418 N/A N/A N/A N/A
Gross Profit 18,670 N/A N/A N/A N/A
Operating Expenses 110,226 58,610 72,429 105,639 60,443
Operating Income -91,138 -58,610 -72,429 -105,639 -60,443
Other Income 9,513 8,842 2,282 4,587 -10,317
Pre-tax Income -81,625 -49,768 -70,147 -101,052 -70,760
Income Tax 502 1 -179 N/A N/A
Net Income Continuous -82,127 -49,769 -69,968 -101,052 -70,760
Net Income $-82,127 $-49,769 $-69,968 $-101,052 $-70,760
EPS Basic Total Ops -2.85 -2.34 -35.71 -12.88 -17.14
EPS Basic Continuous Ops -2.85 -2.34 -35.72 -12.89 -17.12
EPS Diluted Total Ops -2.85 -2.34 -35.71 -12.88 -17.14
EPS Diluted Continuous Ops -2.85 -2.34 -35.72 -12.89 -17.12
EPS Diluted Before Non-Recurring Items -2.85 -2.34 N/A -12.88 -17.15
EBITDA(a) $-90,851 $-58,552 $-73,471 $-104,887 $-59,709
(Values in U.S. thousands)
Next
  03-2026 12-2025 09-2025 06-2025 03-2025
Sales 1,901 1,588 12,500 5,000 0
Cost of Goods 1,076 N/A N/A N/A N/A
Gross Profit 825 1,170 12,500 5,000 N/A
Operating Expenses 45,036 40,051 31,387 21,857 16,931
Operating Income -44,135 -38,463 -18,887 -16,857 -16,931
Other Income 2,647 2,569 2,187 2,445 2,312
Pre-tax Income -41,488 -35,894 -16,700 -14,412 -14,619
Income Tax N/A 2 N/A 500 N/A
Net Income Continuous -41,488 -35,896 -16,700 -14,912 -14,619
Net Income $-41,488 $-35,896 $-16,700 $-14,912 $-14,619
EPS Basic Total Ops -1.32 -1.20 -0.59 -0.53 -0.53
EPS Basic Continuous Ops -1.32 -1.20 -0.59 -0.53 -0.53
EPS Diluted Total Ops -1.32 -1.20 -0.59 -0.53 -0.53
EPS Diluted Continuous Ops -1.32 -1.20 -0.59 -0.53 -0.53
EPS Diluted Before Non-Recurring Items N/A -1.16 -0.59 -0.53 -0.53
EBITDA(a) $-44,024 $-38,356 $-16,740 $-18,860 $-16,895
(Values in U.S. thousands)
Next
  12-2025 12-2024 12-2023 12-2022 12-2021
Assets
Current Assets
Cash & Cash Equivalents 25,179 20,272 35,140 47,730 376,976
Marketable Securities 267,168 188,872 30,654 220,499 N/A
Receivables 329 N/A N/A N/A N/A
Inventories 2,936 0 N/A N/A N/A
TOTAL $301,412 $211,917 $67,244 $275,365 $381,736
Non-Current Assets
PPE Net 1,189 651 54 22,630 6,507
Investments And Advances 0 0 0 15,322 0
Other Non-Current Assets 3,275 2,736 3,078 8,585 13,744
TOTAL $4,464 $3,387 $3,132 $46,537 $20,251
Total Assets $305,876 $215,304 $70,376 $321,902 $401,987
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 4,167 4,257 5,711 2,608 2,453
Accrued Expenses 17,020 6,149 12,803 6,390 4,208
TOTAL $21,187 $10,406 $18,514 $13,043 $12,143
Non-Current Liabilities
Other Non-Current Liabilities 350 814 144,574 12,568 5,794
TOTAL $350 $814 $144,574 $12,568 $5,794
Total Liabilities $21,537 $11,220 $163,088 $25,611 $17,937
Shareholders' Equity
Shares Outstanding, K 31,354 27,543 8,322 8,312 8,290
Common Shares 1 1 10 1 1
Retained earnings -227,141 -145,014 -95,245 -242,403 -141,351
Other shareholders' equity 242 196 6 -1,048 0
TOTAL $284,339 $204,084 $-92,712 $296,291 $384,050
Total Liabilities And Equity $305,876 $215,304 $70,376 $321,902 $401,987
(Values in U.S. thousands)
Next
  03-2026 12-2025 09-2025 06-2025 03-2025
Assets
Current Assets
Cash & Cash Equivalents 24,772 25,179 25,399 37,722 23,156
Marketable Securities 233,613 267,168 176,773 171,911 170,934
Receivables 343 329 N/A N/A N/A
Inventories 3,498 2,936 949 N/A N/A
TOTAL $268,367 $301,412 $206,997 $213,602 $197,859
Non-Current Assets
PPE Net 1,096 1,189 1,258 1,169 926
Other Non-Current Assets 3,072 3,275 2,449 2,561 2,467
TOTAL $4,168 $4,464 $3,707 $3,730 $3,393
Total Assets $272,535 $305,876 $210,704 $217,332 $201,252
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 10,929 4,167 4,323 2,854 3,661
Accrued Expenses 14,877 17,020 11,993 7,544 4,908
TOTAL $25,806 $21,187 $16,316 $10,398 $8,569
Non-Current Liabilities
Other Non-Current Liabilities 237 350 461 569 673
TOTAL $237 $350 $461 $569 $673
Total Liabilities $26,043 $21,537 $16,777 $10,967 $9,242
Shareholders' Equity
Shares Outstanding, K 31,354 31,354 31,290 28,522 28,146
Common Shares 1 1 1 1 1
Retained earnings -268,629 -227,141 -191,245 -174,545 -159,633
Other shareholders' equity -450 242 227 38 123
TOTAL $246,492 $284,339 $193,927 $206,365 $192,010
Total Liabilities And Equity $272,535 $305,876 $210,704 $217,332 $201,252
(Values in U.S. thousands)
Next
  12-2025 12-2024 12-2023 12-2022 12-2021
Cash Flows From Operating Activities
Net Income -82,127 -49,769 -69,968 -101,052 -70,760
Depreciation Amortization 287 58 -1,042 752 734
Accounts receivable -329 N/A N/A N/A N/A
Accounts payable and accrued liabilities -90 -4,279 856 194 1,825
Other Working Capital 3,253 -11,755 9,410 -7,208 -2,498
Other Operating Activity 9,836 6,354 364 19,334 17,847
Operating Cash Flow $-69,170 $-59,391 $-60,380 $-87,980 $-52,852
Cash Flows From Investing Activities
PPE Investments -827 -468 -30 -6,594 -5,740
Purchase Of Investment -280,803 -241,911 -52,091 -405,519 N/A
Sale Of Investment 205,962 87,900 22,500 170,250 N/A
Investing Cash Flow $-75,668 $-154,479 $-29,621 $-241,863 $-5,740
Cash Flows From Financing Activities
Common Stock Issued 1,996 83,551 203 676 623
Common Stock Repurchased N/A N/A N/A -79 N/A
Other Financing Activity 147,749 115,451 80,497 0 416,844
Financing Cash Flow $149,745 $199,002 $80,700 $597 $417,467
Beginning Cash Position 20,272 35,140 44,441 378,692 19,817
End Cash Position 25,179 20,272 35,140 49,446 378,692
Net Cash Flow $4,907 $-14,868 $-9,301 $-329,246 $358,875
Free Cash Flow
Operating Cash Flow -69,170 -59,391 -60,380 -87,980 -52,852
Capital Expenditure -827 -468 -30 -6,594 -5,740
Free Cash Flow -69,997 -59,859 -60,410 -94,574 -58,592
(Values in U.S. thousands)
Next
  03-2026 12-2025 09-2025 06-2025 03-2025
Cash Flows From Operating Activities
Net Income -41,488 -82,127 -46,231 -29,531 -14,619
Depreciation Amortization 111 287 180 -1,967 36
Accounts receivable -14 -329 N/A N/A N/A
Accounts payable and accrued liabilities 6,762 -90 66 -1,628 -771
Other Working Capital 3,378 3,253 3,756 -1,541 -2,969
Other Operating Activity -2,331 9,836 6,084 7,110 2,274
Operating Cash Flow $-33,582 $-69,170 $-36,145 $-27,557 $-16,049
Cash Flows From Investing Activities
PPE Investments -18 -827 -789 -350 -110
Purchase Of Investment -16,056 -280,803 -147,691 -91,385 -33,091
Sale Of Investment 49,235 205,962 162,622 110,210 52,090
Investing Cash Flow $33,161 $-75,668 $14,142 $18,475 $18,889
Cash Flows From Financing Activities
Common Stock Issued 14 1,996 27,130 26,532 44
Other Financing Activity 0 147,749 0 0 0
Financing Cash Flow $14 $149,745 $27,130 $26,532 $44
Beginning Cash Position 25,179 20,272 20,272 20,272 20,272
End Cash Position 24,772 25,179 25,399 37,722 23,156
Net Cash Flow $-407 $4,907 $5,127 $17,450 $2,884
Free Cash Flow
Operating Cash Flow -33,582 -69,170 -36,145 -27,557 -16,049
Capital Expenditure -18 -827 -789 -350 -110
Free Cash Flow -33,600 -69,997 -36,934 -27,907 -16,159

Research

Analysis

Earnings Estimate

GAAP
Normalized
Currency in USD
Current Qtr. (Jun 2026)
Next Qtr. (Sep 2026)
Current Year (2026)
Next Year (2027)
No. of Analysts 7 7 7 7
Avg. Estimate -1.07 -1.02 -4.56 -3.47
Low Estimate -1.37 -1.42 -5.56 -5.09
High Estimate -0.53 -0.7 -3.55 -1.58
Year Ago EPS -0.53 -0.59 -2.85 -4.56

Revenue Estimate

Currency in USD
Current Qtr. (Jun 2026)
Next Qtr. (Sep 2026)
Current Year (2026)
Next Year (2027)
No. of Analysts 7 7 7 7
Avg. Estimate 2.49M 6.92M 19.04M 64.52M
Low Estimate 1.8M 3.39M 12.85M 23.6M
High Estimate 3.3M 9.2M 24.85M 100M
Year Ago Sales 5M 12.5M 19.09M 19.04M
Sales Growth (year/est) -50.11% -44.61% -0.25% 238.87%

Earnings History

GAAP
Normalized
Currency in USD
6/30/2025
9/30/2025
12/31/2025
3/31/2026
EPS Est. -0.54 -0.69 -0.92 -1.07
EPS Actual -0.53 -0.59 -1.16 -1.32
Difference 0.01 0.1 -0.24 -0.25
Surprise % 2.61% 14.75% -25.54% -23.30%

EPS Trend

GAAP
Normalized
Currency in USD
Current Qtr. (Jun 2026)
Next Qtr. (Sep 2026)
Current Year (2026)
Next Year (2027)
Current Estimate -1.07 -1.02 -4.56 -3.47
7 Days Ago -0.99 -0.96 -4 -3.03
30 Days Ago -0.94 -0.9 -3.79 -2.63
60 Days Ago -0.7 -0.66 -2.99 -0.83
90 Days Ago -0.7 -0.66 -2.99 -0.83

EPS Revisions

GAAP
Normalized
Currency in USD
Current Qtr. (Jun 2026)
Next Qtr. (Sep 2026)
Current Year (2026)
Next Year (2027)
Up Last 7 Days 1 3 1 1
Up Last 30 Days 1 3 -- 1
Down Last 7 Days 4 3 5 4
Down Last 30 Days 4 3 6 4

Growth Estimates

Symbol Current Qtr.Next Qtr.Current YearNext Year
LENZ -101.71%-72.66%-60.03%23.95%
S&P 500 25.93%20.24%22.83%16.53%